BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eraña H, Charco JM, Di Bari MA, Díaz-Domínguez CM, López-Moreno R, Vidal E, González-Miranda E, Pérez-Castro MA, García-Martínez S, Bravo S, Fernández-Borges N, Geijo M, D'Agostino C, Garrido J, Bian J, König A, Uluca-Yazgi B, Sabate R, Khaychuk V, Vanni I, Telling GC, Heise H, Nonno R, Requena JR, Castilla J. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies. PLoS Pathog 2019;15:e1008117. [PMID: 31644574 DOI: 10.1371/journal.ppat.1008117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Walsh DJ, Schwind AM, Noble GP, Supattapone S. Conformational diversity in purified prions produced in vitro. PLoS Pathog 2023;19:e1011083. [PMID: 36626391 DOI: 10.1371/journal.ppat.1011083] [Reference Citation Analysis]
2 Vidal E, Sánchez-Martín MA, Eraña H, Lázaro SP, Pérez-Castro MA, Otero A, Charco JM, Marín B, López-Moreno R, Díaz-Domínguez CM, Geijo M, Ordóñez M, Cantero G, di Bari M, Lorenzo NL, Pirisinu L, d'Agostino C, Torres JM, Béringue V, Telling G, Badiola JJ, Pumarola M, Bolea R, Nonno R, Requena JR, Castilla J. Bona fide atypical scrapie faithfully reproduced for the first time in a rodent model. Acta Neuropathol Commun 2022;10:179. [PMID: 36514160 DOI: 10.1186/s40478-022-01477-7] [Reference Citation Analysis]
3 Ma J, Zhang J, Yan R. Recombinant Mammalian Prions: The “Correctly” Misfolded Prion Protein Conformers. Viruses 2022;14:1940. [DOI: 10.3390/v14091940] [Reference Citation Analysis]
4 Martín-pastor M, Codeseira YB, Spagnolli G, Eraña H, Fernández LC, Martin D, Bravo S, López-lorenzo N, Iglesias A, López-moreno R, Sabaté R, Veiga S, Rezaei H, Biasini E, Sánchez-pedregal VM, Castilla J, Requena JR. Solid state NMR reveals a parallel in register architecture for an infectious recombinant prion.. [DOI: 10.1101/2021.07.20.453078] [Reference Citation Analysis]
5 Spagnolli G, Massignan T, Astolfi A, Biggi S, Rigoli M, Brunelli P, Libergoli M, Ianeselli A, Orioli S, Boldrini A, Terruzzi L, Bonaldo V, Maietta G, Lorenzo NL, Fernandez LC, Codeseira YB, Tosatto L, Linsenmeier L, Vignoli B, Petris G, Gasparotto D, Pennuto M, Guella G, Canossa M, Altmeppen HC, Lolli G, Biressi S, Pastor MM, Requena JR, Mancini I, Barreca ML, Faccioli P, Biasini E. Pharmacological inactivation of the prion protein by targeting a folding intermediate. Commun Biol 2021;4:62. [PMID: 33437023 DOI: 10.1038/s42003-020-01585-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
6 Moudjou M, Castille J, Passet B, Herzog L, Reine F, Vilotte JL, Rezaei H, Béringue V, Igel-Egalon A. Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments. Front Bioeng Biotechnol 2020;8:591024. [PMID: 33335894 DOI: 10.3389/fbioe.2020.591024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Eraña H, Pérez-Castro MÁ, García-Martínez S, Charco JM, López-Moreno R, Díaz-Dominguez CM, Barrio T, González-Miranda E, Castilla J. A Novel, Reliable and Highly Versatile Method to Evaluate Different Prion Decontamination Procedures. Front Bioeng Biotechnol 2020;8:589182. [PMID: 33195153 DOI: 10.3389/fbioe.2020.589182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Spagnolli G, Rigoli M, Novi Inverardi G, Codeseira YB, Biasini E, Requena JR. Modeling PrPSc Generation Through Deformed Templating. Front Bioeng Biotechnol 2020;8:590501. [PMID: 33123520 DOI: 10.3389/fbioe.2020.590501] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bohl J, Sicard C, Rezaei H, Van der Rest G, Halgand F. Evidence of conformational landscape alteration and macromolecular complex formation in the early stages of in vitro human prion protein oxidation. Arch Biochem Biophys 2020;690:108432. [PMID: 32663474 DOI: 10.1016/j.abb.2020.108432] [Reference Citation Analysis]
10 Spagnolli G, Requena JR, Biasini E. Understanding prion structure and conversion. Prog Mol Biol Transl Sci 2020;175:19-30. [PMID: 32958233 DOI: 10.1016/bs.pmbts.2020.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Arshad H, Bourkas MEC, Watts JC. The utility of bank voles for studying prion disease. Prog Mol Biol Transl Sci 2020;175:179-211. [PMID: 32958232 DOI: 10.1016/bs.pmbts.2020.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Martín-pastor M, Codeseira YB, Spagnolli G, Eraña H, Fernández LC, Bravo S, Iglesias A, López-moreno R, Veiga S, Biasini E, Sánchez-pedregal VM, Castilla J, Requena JR. Structural features of an infectious recombinant PrPSc prion using solid state NMR.. [DOI: 10.1101/2020.04.08.032839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Spagnolli G, Massignan T, Astolfi A, Biggi S, Brunelli P, Libergoli M, Ianeselli A, Orioli S, Boldrini A, Terruzzi L, Maietta G, Rigoli M, Lorenzo NL, Fernandez LC, Tosatto L, Linsenmeier L, Vignoli B, Petris G, Gasparotto D, Pennuto M, Guella G, Canossa M, Altmeppen HC, Lolli G, Biressi S, Pastor MM, Requena JR, Mancini I, Barreca ML, Faccioli P, Biasini E. PHARMACOLOGICAL PROTEIN INACTIVATION BY TARGETING FOLDING INTERMEDIATES.. [DOI: 10.1101/2020.03.31.018069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Eraña H, Charco JM, González-Miranda E, García-Martínez S, López-Moreno R, Pérez-Castro MA, Díaz-Domínguez CM, García-Salvador A, Castilla J. Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules 2020;10:E469. [PMID: 32204429 DOI: 10.3390/biom10030469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Nakagawa Y, Yamada S. Metal homeostasis disturbances in neurodegenerative disorders, with special emphasis on Creutzfeldt-Jakob disease - Potential pathogenetic mechanism and therapeutic implications. Pharmacol Ther 2020;207:107455. [PMID: 31863817 DOI: 10.1016/j.pharmthera.2019.107455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]